| Issue Date |
Title |
Author(s) |
| 2019 |
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial |
Li, Wen-Fei;Chen, Nian-Yong;Zhang, Ning;Hu, Guo-Qing;Xie, Fang-Yun;Sun, Yan;Chen, Xiao-Zhong;Li, Jin-Gao;Zhu, Xiao-Dong;Hu, Chao-Su;Xu, Xiang-Ying;Chen, Yuan-Yuan;Hu, Wei-Han;Guo, Ling;Mo, Hao-Yuan;Chen, Lei;Mao, Yan-Ping;Sun, Rui;Ai, Ping;Liang, Shao-Bo;Long, Guo-Xian;Zheng, Bao-Min;Feng, Xing-Lai;Gone, Xiao-Chang;Li, Ling;Shen, Chun-Ying;Xu, Jian-Yu;Guo, Ying;Chen, Yu-Ming;Zhang, Fan;Lin, Li;Tang, Ling-Long;Liu, Meng-Zhong;Ma, Jun;Sun, Ying |
| 2019 |
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma |
Zhang, Yuan;Chen, Lei;Hu, Guo-Qing;Zhang, Ning;Zhu, Xiao-Dong;Yang, Kun-Yu;Jin, Feng;Shi, Mei;Chen, Yu-Pei;Hu, Wei-Han;Cheng, Zhi-Bin;Wang, Si-Yang;Tian, Ye;Wang, Xi-Cheng;Sun, Yan;Li, Jin-Gao;Li, Wen-Fei;Li, Yu-Hong;Tang, Ling-Long;Mao, Yan-Ping;Zhou, Guan-Qun;Sun, Rui;Liu, Xu;Guo, Rui;Long, Guo-Xian;Liang, Shao-Qiang;Li, Ling;Huang, Jing;Long, Jin-Hua;Zang, Jian;Liu, Qiao-Dan;Zou, Li;Su, Qiong-Fei;Zheng, Bao-Min;Xiao, Yun;Guo, Ying;Han, Fei;Mo, Hao-Yuan;Lv, Jia-Wei;Du, Xiao-Jing;Xu, Cheng;Liu, Na;Li, Ying-Qin;Chua, Melvin L. K.;Xie, Fang-Yun;Sun, Ying;Ma, Jun |
| 2016 |
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial |
Sun, Ying;Li, Wen-Fei;Chen, Nian-Yong;Zhang, Ning;Hu, Guo-Qing;Xie, Fang-Yun;Sun, Yan;Chen, Xiao-Zhong;Li, Jin-Gao;Zhu, Xiao-Dong;Hu, Chao-Su;Xu, Xiang-Ying;Chen, Yuan-Yuan;Hu, Wei-Han;Guo, Ling;Mo, Hao-Yuan;Chen, Lei;Mao, Yan-Ping;Sun, Rui;Ai, Ping;Liang, Shao-Bo;Long, Guo-Xian;Zheng, Bao-Min;Feng, Xing-Lai;Gong, Xiao-Chang;Li, Ling;Shen, Chun-Ying;Xu, Jian-Yu;Guo, Ying;Chen, Yu-Ming;Zhang, Fan;Lin, Li;Tang, Ling-Long;Liu, Meng-Zhong;Ma, Jun |
| 24-Jul-2021 |
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
Chen, Yu-Pei;Liu, Xu;Zhou, Qin;Yang, Kun-Yu;Jin, Feng;Zhu, Xiao-Dong;Shi, Mei;Hu, Guo-Qing;Hu, Wei-Han;Sun, Yan;Wu, Hong-Fen;Wu, Hui;Lin, Qin;Wang, Hui;Tian, Ye;Zhang, Ning;Wang, Xi-Cheng;Shen, Liang-Fang;Liu, Zheng-Zheng;Huang, Jing;Luo, Xiu-Ling;Li, Ling;Zang, Jian;Mei, Qi;Zheng, Bao-Min;Yue, Dan;Xu, Jing;Wu, San-Gang;Shi, Yan-Xia;Mao, Yan-Ping;Chen, Lei;Li, Wen-Fei;Zhou, Guan-Qun;Sun, Rui;Guo, Rui;Zhang, Yuan;Xu, Cheng;Lv, Jia-Wei;Guo, Ying;Feng, Hui-Xia;Tang, Ling-Long;Xie, Fang-Yun;Sun, Ying;Ma, Jun |
